NASDAQ
Kaken Pharmaceutical Co., Ltd. (KKPCF) has a revenue compound annual growth rate of 0.63% over 5 years and -3.39% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.